SOURCE: Key Capital Corporation

January 08, 2007 11:42 ET

Key Capital Participating in Friedland Investment Event Conferences

SANTA CLARA, CA -- (MARKET WIRE) -- January 8, 2007 -- Key Capital Corporation (PINKSHEETS: KCPC) advises the Company will be presenting at several upcoming Friedland Investment Events conferences. The first presentation will be at the Friedland Microcap Conference on January 25, 2007 in New York, followed by a Life Sciences Conference in Orange County on February 7, 2007 and a China Conference on February 13, 2007 in New York. A number of further Life Sciences, Biotech and Global Equity conferences are also scheduled through the course of the current year.

Qualified members of the financial community are invited to attend the conferences. For complimentary tickets or more information contact Friedland Investment Events at 1-212-757-9454, or

About Key Capital:

Key Capital is in the process of, and subject to Chinese regulatory approval, acquiring Beijing-based Healthstar Medical Development Company, and dual listing on the London AIM Exchange. Healthstar is a fully integrated pharmaceutical company, with research, clinical, regulatory, manufacturing and marketing capabilities and facilities in China. Consolidated 2006 revenues exceeded US$500,000 per week and 2007 revenue is forecast in excess of an average US$700,000 per week.

Healthstar is a profitable established pharmaceutical business that is well positioned for further growth in the Chinese domestic market through the launch of three new proprietary drugs this year.

--  A cancer treatment drug having specific application to liver cancer as
    well as other cancers.  It has been in development for approximately 8
    years and has a target market of over 450,000 new cases of liver cancer
    diagnosed in China each year.
--  An osteoporosis treatment that can significantly increase bone mineral
    density as well as promote new growth.  The prevalence of osteoporosis in
    China represents a massive market with approximately 20% of all females and
    11.5% of males over 40 affected.
--  A hemostatic product that can be effective for controlling excessive
    bleeding or traumatic hemorrhage, especially in surgical practice.
Healthstar's plan is to continue its exceptional growth in China and to gradually emerge as a global company as it launches its products in the western world.

About Friedland Investment Events:

Friedland Investment Events LLC is the world's largest sponsor of financial and investment events, sponsoring hundreds of events annually in 18 US and three European cities. These investment events typically feature presentations by management to buy-side and sell-side members of the investment community, investors and industry interests as well as presentations by sponsors of investment programs for financial planners, brokers, accountants and investment advisors. See:

Safe Harbor Statement

The information in this release, other than historical information, may be considered forward-looking statements within the provisions of the Private Securities Litigation Reform Act of 1995. Projection and other forward-looking statements and management expectations regarding future events and/or financial performance of the Company -- although given in good faith -- are inherently uncertain and actual events and/or results may differ materially.

Contact Information